C12Y 304/21108
Htra2 peptidase
Official title: HtrA2 peptidase (3.4.21.108)
C12Y304/21108 (Htra2 peptidase) appears on 0 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 5
- Assignees
- 3
- Inventors
- 20
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Compositions and methods for enhancing cardiomyocyte transplant engraftment13 Mar 2025US 2025/0082689 A1International Centre for Genetic Engineering and Biotechnology (Icgeb)
- Antisense oligonucleotides for modulating htra1 expression10 Feb 2022US 2022/0042022 A1
- Companion diagnostic for htra1 rna antagonists3 Dec 2020US 2020/0378970 A1Hoffmann-La Roche Inc.
- Antisense oligonucleotides for modulating htra1 expression21 May 2020US 2020/0157546 A1
- Antisense oligonucleotides for modulating htra1 expression21 Feb 2019US 2019/0055564 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.